A trial of human antithrombin III

Trial Profile

A trial of human antithrombin III

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 25 Oct 2016

At a glance

  • Drugs Antithrombin III (Primary)
  • Indications Antithrombin III deficiency
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 25 Oct 2016 New trial record
    • 11 Oct 2016 According to a China Biologic Products, Inc. media release, the China Food and Drug Administration (CFDA) has granted approval to begin human clinical trials with Human Antithrombin III product.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top